- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02289742
Tear Film Evaluation of Dailies® AquaComfort Plus® Multifocal and Toric
June 15, 2016 updated by: Alcon Research
Characterization of Pre-Lens Tear Film Stability of Daily Disposable Multifocal and Toric Contact Lenses Using Ring Mire Projection
The purpose of this study is to evaluate the pre lens tear film characteristics of DAILIES® Aqua Comfort Plus® Multifocal (DACP MF) and Toric (DACP Toric) compared to DAILIES® Aqua Comfort Plus® Sphere (DACP) daily disposable contact lenses over 12 hours of lens wear.
Study Overview
Status
Completed
Conditions
Detailed Description
Two population groups (presbyopes and astigmats) will be enrolled in the study.
Study Type
Interventional
Enrollment (Actual)
48
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Must sign an informed consent document;
Adapted, current soft contact lens wearer with either:
- A spectacle add between +0.50 and +2.50 (inclusive) [Presbyopes group]
- A spherical correction of an astigmatism up to 20% of the amount of the sphere [Astigmats group];
- Contact lens prescription in the power range specified in the protocol;
- Vision correctable to 0.2 logMAR (logarithmic minimal angle for resolution) or better in each eye at distance with pre-study lenses or manifest refraction at Visit 1;
- Willing to wear study lenses up to 12 hours and attend all study visits;
- Can be successfully fitted with study lenses;
- Other protocol-specified inclusion criteria may apply.
Exclusion Criteria:
- Any ocular anterior segment infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear;
- Use of systemic or ocular medications for which contact lens wear could be contraindicated as determined by the investigator;
- Use of artificial tears and rewetting drops during the study;
- Monocular (only 1 eye with functional vision) or fit with only 1 lens;
- Any abnormal ocular condition observed during the Visit 1 slit-lamp examination;
- History of herpetic keratitis, ocular surgery, or irregular cornea;
- Pregnant or lactating;
- Unstable tear film with a NIK-BUT value below 8 seconds in either eye without lenses;
- Participation in any clinical study within 30 days of Visit 1;
- Other protocol-specified exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Arm1: Presbyopes
Nelfilcon A contact lenses (multifocal and sphere) worn as randomized in a crossover design during Periods 1 and 2, with nelfilcon A sphere contact lenses in Period 3.
Each product worn bilaterally (in both eyes) for 12 hours.
|
Other Names:
Other Names:
|
Other: Arm2: Astigmats
Nelfilcon A contact lenses (toric and sphere) worn as randomized in a crossover design during Periods 1 and 2, with nelfilcon A sphere contact lenses in Period 3.
Each product worn bilaterally (in both eyes) for 12 hours.
|
Other Names:
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of Subjects With Wettability Grade of 2 or 3 After 12 Hours of Wear
Time Frame: Hour 12, each product
|
A video was made to capture a visual demonstration of tear film characteristics in between blinks.
The investigator graded contact lens surface wettability using a scale from 0 (fully wettable) to 3 (clearly visible distortions) at 5, 10, 15, 20 and 25 seconds post-blink by region (central, superior, nasal, inferior, and temporal).
Three independent measurements (3 blinks) were carried out.
An average was taken over the 3 measurements, 5 regions, and 5 time points.
One eye contributed to the analysis.
|
Hour 12, each product
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of Subjects With Wettability Grade of 2 or 3 After 8 Hours of Wear
Time Frame: Hour 8, each product
|
A video was made to capture a visual demonstration of tear film characteristics in between blinks.
The investigator graded contact lens surface wettability using a scale from 0 (fully wettable) to 3 (clearly visible distortions) at 5, 10, 15, 20 and 25 seconds post-blink by region (central, superior, nasal, inferior, and temporal).
Three independent measurements (3 blinks) were carried out.
An average was taken over the 3 measurements, 5 regions, and 5 time points.
One eye contributed to the analysis.
|
Hour 8, each product
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Sr. Clinical Manager, Global Med Affairs, Operations, Alcon Research
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2014
Primary Completion (Actual)
March 1, 2015
Study Completion (Actual)
March 1, 2015
Study Registration Dates
First Submitted
November 10, 2014
First Submitted That Met QC Criteria
November 10, 2014
First Posted (Estimate)
November 13, 2014
Study Record Updates
Last Update Posted (Estimate)
July 26, 2016
Last Update Submitted That Met QC Criteria
June 15, 2016
Last Verified
June 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- M-14-010
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Refractive Error
-
Alcon ResearchCompletedRefractive Error - Myopia Severe | Refractive Error - Myopia SimpleUnited States, Ireland, Singapore
-
Vision Service PlanCompletedRefractive Error - Myopia BilateralUnited States
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vision Service PlanCompletedRefractive Error - Myopia BilateralUnited States
-
Wang HongxiaTianjin Eye HospitalCompletedRefractive Error - Myopia AxialChina
-
Tianjin Eye HospitalRecruitingMyopia; Refractive ErrorChina
-
Abbott Medical OpticsCompletedStable Myopic Refractive Error, With or Without AstigmatismUnited States
-
KK Women's and Children's HospitalWithdrawnRefractive Error - Myopia
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Alcon ResearchCompletedRefractive ErrorsUnited States
Clinical Trials on Nelfilcon A toric contact lenses
-
CIBA VISIONCompletedRefractive Error | Astigmatism | Myopia
-
Alcon ResearchCompleted
-
Johnson & Johnson Vision Care, Inc.Completed
-
Coopervision, Inc.Completed
-
Alcon ResearchCompletedRefractive Error | Presbyopia
-
CIBA VISIONCompletedAstigmatism | Myopia
-
Alcon ResearchCompletedRefractive Errors | AstigmatismUnited States
-
Johnson & Johnson Vision Care, Inc.CompletedRefractive ErrorsUnited Kingdom
-
Alcon ResearchCompletedAstigmatism | Myopia | AmetropiaUnited States
-
Alcon ResearchCompletedAstigmatismUnited States